Literature DB >> 34019160

HPV Vaccination in Bangladesh: Ethical Views.

Marium Salwa1, Tarek Abdullah Al-Munim2.   

Abstract

Human papillomavirus (HPV) vaccination of young adolescent girls as a part of primary prevention of cervical cancer is now a routine practice in many countries. Bangladesh, a lower-middle income country, observed a successful HPV vaccination demonstration program recently. As much as the benefits of the vaccination programs are well-recorded, the ethics of administration of it is not focused highly; rather the focus tends to be on the most efficient method to get it done. In countries like Bangladesh, vaccination-related ethical issues are often overlooked. Thus, addition of HPV vaccination to the existing immunization programs calls for logical discussion and consideration to preserve the highest ethical standard in administering this vaccine to a sensitive age group of adolescence. This chapter summarizes some ethical concerns related to the HPV vaccination implementation in Bangladesh.

Entities:  

Keywords:  Adolescent; Bangladesh; Cervical cancer; Human papillomavirus vaccine (HPV)

Year:  2021        PMID: 34019160     DOI: 10.1007/978-3-030-63749-1_3

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  8 in total

1.  Cervical cancer incidence can increase despite HPV vaccination.

Authors:  Diane M Harper; Pekka Nieminen; Jorma Paavonen; Matti Lehtinen
Journal:  Lancet Infect Dis       Date:  2010-09       Impact factor: 25.071

Review 2.  Challenges of implementing human papillomavirus (HPV) vaccination policy.

Authors:  Angela E Raffle
Journal:  BMJ       Date:  2007-08-25

3.  Evaluation of the National Cervical Cancer Screening Programme of Bangladesh and the formulation of quality assurance guidelines.

Authors:  Partha Basu; Ashrafun Nessa; Murtaza Majid; Jebun Nessa Rahman; Tahera Ahmed
Journal:  J Fam Plann Reprod Health Care       Date:  2010-07

4.  Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.

Authors:  G M Clifford; S Gallus; R Herrero; N Muñoz; P J F Snijders; S Vaccarella; P T H Anh; C Ferreccio; N T Hieu; E Matos; M Molano; R Rajkumar; G Ronco; S de Sanjosé; H R Shin; S Sukvirach; J O Thomas; S Tunsakul; C J L M Meijer; S Franceschi
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

Review 5.  Ethical analysis of HPV vaccine policy options.

Authors:  Richard K Zimmerman
Journal:  Vaccine       Date:  2006-03-23       Impact factor: 3.641

6.  HPV and cervical cancer prevention counseling with younger adolescents: implications for primary care.

Authors:  Andrew L Sussman; Deborah Helitzer; Margaret Sanders; Brisa Urquieta; Melina Salvador; Khadidiatou Ndiaye
Journal:  Ann Fam Med       Date:  2007 Jul-Aug       Impact factor: 5.166

7.  The association between knowledge of HPV and feelings of stigma, shame and anxiety.

Authors:  J Waller; L A V Marlow; J Wardle
Journal:  Sex Transm Infect       Date:  2006-11-10       Impact factor: 3.519

8.  Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.

Authors:  Md Jasim Uddin; Gourab Adhikary; Md Wazed Ali; Shahabuddin Ahmed; Md Shamsuzzaman; Chris Odell; Lauren Hashiguchi; Stephen S Lim; Nurul Alam
Journal:  BMC Infect Dis       Date:  2016-08-12       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.